Alvotech and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced that the FDA has approved Selarsdi (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara, for the treatment of moderate to severe plaque psoriasis and for active psoriatic arthritis in adults and pediatric patients 6 years and older
The FDA has approved Eli Lilly's Humulin R U-500 KwikPen (insulin human injection) 500 units/mL, a pre-filled device containing Humulin...
Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced the availability of the first FDA-approved generic versions of Truvada and Atripla tablets ( namely Emtricitabine and Tenofovir Disoproxil Fumarate Tablets).